Steroid use has been shown to increase LDL and HDL, as well as apoA1 levels in patients with autoimmune disease [25], and short-term steroid use may increase the levels of lecithin cholesterol acetyl transferase (LCAT) and increase levels of HDL2 [26]. This evidence concerns the gene APOA1 and autoimmune disease.